A phase II study of radioimmunotherapy with intraventricular 131 I-3F8 for medulloblastoma.
Kramer K, Pandit-Taskar N, Humm JL, Zanzonico PB, Haque S, Dunkel IJ, Wolden SL, Donzelli M, Goldman DA, Lewis JS, Lyashchenko SK, Khakoo Y, Carrasquillo JA, Souweidane MM, Greenfield JP, Lyden D, De Braganca KD, Gilheeney SW, Larson SM, Cheung NV.
Kramer K, et al. Among authors: cheung nv.
Pediatr Blood Cancer. 2018 Jan;65(1):10.1002/pbc.26754. doi: 10.1002/pbc.26754. Epub 2017 Sep 22.
Pediatr Blood Cancer. 2018.
PMID: 28940863
Free PMC article.
Clinical Trial.